%0 Journal Article
%T Biological differences between adult and perinatal human mesenchymal stromal cells and their impact on the manufacturing processes.
%A Silva Couto P
%A Stibbs DJ
%A Rotondi MC
%A Khalife R
%A Wolf D
%A Takeuchi Y
%A Rafiq QA
%J Cytotherapy
%V 0
%N 0
%D 2024 May 31
%M 38970611
%F 6.196
%R 10.1016/j.jcyt.2024.05.020
%X The biological properties of human mesenchymal stromal cells (hMSCs) have been explored in over a thousand clinical trials in the last decade. Although hMSCs can be isolated from multiple sources, the degree of biological similarity between cell populations from these sources remains to be determined. A comparative study was performed investigating the growth kinetics and functionality of hMSCs isolated from adipose tissue (AT), bone marrow (BM) and umbilical cord tissue (UCT) expanded in monolayer over five passages. Adult hMSCs (AT, BM) had a slower proliferation ability than the UCT-hMSCs, with no apparent differences in their glucose consumption profile. BM-hMSCs produced higher concentrations of endogenous vascular endothelial growth factor (VEGF) compared to AT- and UCT-hMSCs. This study also revealed that UCT-hMSCs were more efficiently transduced by a lentiviral vector carrying a VEGF gene than their adult counterparts. Following cellular immunophenotypic characterization, no differences across the sources were found in the expression levels of the typical markers used to identify hMSCs. This work established a systematic approach for cell source selection depending on the hMSC's intended clinical application.